PRISM BioLabLTD Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Dai Takehara

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure9yrs
CEO ownership3.3%
Management average tenureno data
Board average tenure3yrs

Recent management updates

Recent updates


CEO

Dai Takehara (61 yo)

9yrs

Tenure

Mr. Dai Takehara is President, Chief Executive Officer since 2016 & Director of PRISM BioLab Co.,LTD. and serves as its Chairperson. He served as Chief Financial Officer at PRISM Pharma Co.,Ltd.since 2011...


Board Members

NamePositionTenureCompensationOwnership
Dai Takehara
Chairmanno datano data3.26%
¥ 305.5m
Shinji Takeuchi
Head of Administrative Department & Directorno datano datano data
Hyi-Man Park
Head of the Research & Development Department & Director3yrsno datano data
Teruhisa Tajima
Outside Audit & Supervisory Board Member6.3yrsno datano data
Shi Yin Foo
Member of Scientific Advisory Boardno datano datano data
Doriano Fabbro
Member of Scientific Advisory Boardno datano datano data
Hiroshi Nagabukuro
Member of Scientific Advisory Boardno datano datano data
Dean Rigel
Member of Scientific Advisory Boardno datano datano data
Hiromi Furushima
Independent Outside Director2.8yrsno datano data
Yuji Ishiguro
Chairperson of Audit & Supervisory Board3yrsno datano data
Kiichiro Kawada
Outside Audit & Supervisory Board Member3.8yrsno datano data
Toshinobu Mamiya
Outside Audit & Supervisory Board Member1.8yrsno datano data

3.0yrs

Average Tenure

61yo

Average Age

Experienced Board: 206A's board of directors are considered experienced (3 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/21 19:57
End of Day Share Price 2025/01/21 00:00
EarningsN/A
Annual EarningsN/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

PRISM BioLab Co.,LTD is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution